ES2136315T3 - Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones. - Google Patents

Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones.

Info

Publication number
ES2136315T3
ES2136315T3 ES95939052T ES95939052T ES2136315T3 ES 2136315 T3 ES2136315 T3 ES 2136315T3 ES 95939052 T ES95939052 T ES 95939052T ES 95939052 T ES95939052 T ES 95939052T ES 2136315 T3 ES2136315 T3 ES 2136315T3
Authority
ES
Spain
Prior art keywords
lungs
contribution
drugs
facilitate
liquid fluorocarbons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95939052T
Other languages
English (en)
Inventor
Gwen H Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Application granted granted Critical
Publication of ES2136315T3 publication Critical patent/ES2136315T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00—Surgery
    • Y10S128/913—Breathable liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EQUIPO QUE INCLUYE UN LIQUIDO DE PERFLUOROCARBONO Y UN MEDICAMENTO MICROPARTICULADO DISPERSO EN UN GAS QUE SE USA EN EL TRATAMIENTO DE UNA AFECCION PULMONAR EN UN MAMIFERO. EL EQUIPO SE USA EN UN METODO DE VARIAS FASES PARA SUMINISTRAR EL MEDICAMENTO A LOS PULMONES. EN ESTE METODO, SE INTRODUCE UN PERFLUOROCARBONO BIOCOMPATIBLE EN LOS PULMONES JUNTO CON UN MEDICAMENTO MICROPARTICULADO, DISPERSANDOSE ESTE EN LOS ESPACIOS PULMONARES QUE SE HALLAN RELLENOS O CUBIERTOS POR EL LIQUIDO DE PERFLUOROCARBONO.
ES95939052T 1994-11-04 1995-11-02 Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones. Expired - Lifetime ES2136315T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/334,688 US5531219A (en) 1994-11-04 1994-11-04 Use of liquid fluorocarbons to facilitate pulmonary drug delivery

Publications (1)

Publication Number Publication Date
ES2136315T3 true ES2136315T3 (es) 1999-11-16

Family

ID=23308353

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95939052T Expired - Lifetime ES2136315T3 (es) 1994-11-04 1995-11-02 Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones.

Country Status (10)

Country Link
US (1) US5531219A (es)
EP (1) EP0789558B1 (es)
JP (1) JPH10508602A (es)
AT (1) ATE182785T1 (es)
AU (1) AU710381B2 (es)
DE (1) DE69511279T2 (es)
DK (1) DK0789558T3 (es)
ES (1) ES2136315T3 (es)
GR (1) GR3031504T3 (es)
WO (1) WO1996014056A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033611B2 (en) 2013-11-04 2021-06-15 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US5829428A (en) * 1996-05-29 1998-11-03 Alliance Pharmaceutical Corp. Methods and apparatus for reducing the loss of respiratory promoters
WO1998006426A1 (en) * 1996-08-14 1998-02-19 Gram Joergen Brodersen Use of a plasminogen activator for the treatment of pulmonary disorders
US6451784B1 (en) * 1996-12-30 2002-09-17 Battellepharma, Inc. Formulation and method for treating neoplasms by inhalation
CA2628857C (en) 1996-12-30 2011-09-13 Batelle Memorial Institute Formulation and method for treating neoplasms by inhalation
CN1123345C (zh) * 1997-02-17 2003-10-08 奥坦纳医药公司 治疗ards或irds的组合物
US20040219149A1 (en) * 2001-06-08 2004-11-04 Yuhong Zhou Methods for the modulation of il-13
WO2000075281A2 (en) 1999-06-09 2000-12-14 University Technology Corporation Supercritical fluid-assisted nebulization and bubble drying
EP1379306A1 (de) * 2001-04-11 2004-01-14 Michael Kandler Vorrichtung zur künstlichen beatmung
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
CA2413041A1 (fr) * 2002-11-29 2004-05-29 Jean-Paul Praud Un appareil permettant d'effectuer des ventilations liquides totales
GB2422310B (en) * 2004-12-02 2006-12-27 Kaizen Matsumoto Carcinogen solvents in reducing the carcinogen concentration of cells
US7909031B2 (en) * 2005-06-09 2011-03-22 Temple Univesity - Of The Commonwealth System of Higher Education Process for transient and steady state delivery of biological agents to the lung via breathable liquids
WO2007071052A1 (en) * 2005-12-21 2007-06-28 Uti Limited Partnership Treatment of respiratory diseases
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
US9028401B1 (en) 2013-11-11 2015-05-12 Cross Bay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
US10034986B2 (en) 2013-11-11 2018-07-31 Crossbay Medical, Inc. Method and apparatus of tubal patency catheter and delivery systems
US10245074B2 (en) 2013-11-11 2019-04-02 Crossbay Medical, Inc. Apparatus and methods for accessing and sealing bodily vessels and cavities
WO2016179447A1 (en) * 2015-05-06 2016-11-10 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
US11318041B2 (en) 2019-10-09 2022-05-03 Crossbay Medical, Inc. Apparatus and method for everting catheter for IUD delivery and placement in the uterine cavity
WO2022081556A1 (en) * 2020-10-12 2022-04-21 Boundless Science, Llc Systems, devices and methods for delivering aerosolized fluorocarbons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5209785A (en) * 1991-10-30 1993-05-11 United Technologies Corporation Non-chlorinated solvent dewax process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033611B2 (en) 2013-11-04 2021-06-15 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway

Also Published As

Publication number Publication date
DK0789558T3 (da) 2000-03-06
WO1996014056A1 (en) 1996-05-17
GR3031504T3 (en) 2000-01-31
DE69511279D1 (de) 1999-09-09
US5531219A (en) 1996-07-02
EP0789558A1 (en) 1997-08-20
DE69511279T2 (de) 2000-01-05
ATE182785T1 (de) 1999-08-15
EP0789558B1 (en) 1999-08-04
AU4101796A (en) 1996-05-31
AU710381B2 (en) 1999-09-16
JPH10508602A (ja) 1998-08-25

Similar Documents

Publication Publication Date Title
ES2136315T3 (es) Uso de fluorocarbonos liquidos para facilitar la aportacion de medicamentos a los pulmones.
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
BR9801008A (pt) Formulação aerossol adequada para terapia, profilaxia ou contenção de infecções da mycobacterium tuberculosis de um pacientes sofrendo de tuberculose
EE9700192A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
EE9700060A (et) 2-arüül-asendatud püridiinid,nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9800136A (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
ES2133130B1 (es) Nueva formulacion de budesonida, su uso y recipiente que la contiene.
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
ES2058284T3 (es) Preparado capilar.
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
IT8423748A0 (it) Derivati polisostituiti di naftalene, relativo procedimento di preparazione e uso in campo farmaceutico e cosmetico.
FI943570A (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
MX9200324A (es) Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene.
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
EE9800075A (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
ES2191206T3 (es) Nueva utilizacion de la creatina.
EE03687B1 (et) Furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
RS49691B (sr) Liofilizovan preparat ljudskog morfogenetskog faktora mp52 kosti
ES2131482A1 (es) Formulacion acuosa de bambuterol.
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 789558

Country of ref document: ES